Monthly Archives: April 2009

It is now approximately 11 months since I posted the first version of the Anti-Aging Firewalls treatise and it is interesting to identify how the current version of the treatise (which might  be considered to be Version 1.9) is different … Continue reading →

A step of progress was reported this week in developing better understanding of the molecular processes underlying Alzheimer’s Disease.  For some time it has been known that beta-amyloid protein shows up in excessive quantities in the brains of Alzheimer’s Disease … Continue reading →

Here are a few recent longevity news tidbits derived from studies published in geriatrics journals.  Two of the news reports confuse cause and effect and project a probably-incorrect message.  ·        Seniors can use computerized brain exercises to improve their memory … Continue reading →

When lifespans of 160+ years become routinely available it will most likely be due to research results coming out of the “omics:”  genomics, epigenomics, proteomics, etc.  This is a short introduction to some of the most important omics and how … Continue reading →

Nutrigenomics is one of the many latest “omics,” a hybrid of research focused on study of the relationships among nutrition and genomics.  A podcast discussing this emerging field can be found here.  The field is concerned with identifying how the … Continue reading →

Nanotechnology is a wild and unregulated frontier.  It could offer great health benefits.  For example,   Japanese researchers have developed a nanoparticle that fuses with cancer but not normal cells and induces apoptosis in those cancer cells(ref).  On another front, there … Continue reading →

On the surface it appears that the 14th theory of aging in my Anti-Aging Firewalls treatise Decline in Adult Stem Cell Differentiation is very different than the  12th theory Telomere Shortening. And these two theories seem to be different than … Continue reading →

There has been a lot of press this week about a study conducted in India using the “Polypill,”  a combination of a beta-blocker, a diuretic, an ace inhibitor, folic acid, a statin and aspirin rolled into a single pill.  The … Continue reading →